UOC
SRTA

UBS O'Connor’s Strata Critical Medical Inc SRTA Stock Holding History

UBS O'Connor’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-456,250
Closed -$5.05M – 820
2020
Q4 		$5.05M Sell
456,250
-684,281
-60% -$6.98M 0.1% 192
2020
Q3 		$11.5M Sell
1,140,531
-1,400,719
-55% -$14.1M 0.29% 49
2020
Q2 		$25.3M Sell
2,541,250
-133,750
-5% -$1.31M 0.56% 27
2020
Q1 		$25.9M Hold
2,675,000
– – 0.53% 25
2019
Q4 		$26.2M Buy
+2,675,000
New +$26.2M 0.74% 18

Other funds holding SRTA

HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
DRS
Deane Retirement Strategies New Orleans, Louisiana $236M AUM 22.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS O'Connor's SRTA Position: Q1 2021 in Review

UBS O'Connor sold out of Strata Critical Medical Inc (SRTA) in Q1 2021, closing a stake of 456,250 shares — an estimated $5.05M sold.

UBS O'Connor first reported a position in SRTA in Q4 2019 and held it in 5 quarters. The position peaked at $26.2M in Q4 2019. 64 funds tracked by Wall St. Rank hold SRTA as of Q1 2021.

  • UBS O'Connor reported no remaining Strata Critical Medical Inc position as of Q1 2021 after selling out during the quarter.
  • UBS O'Connor sold 456,250 Strata Critical Medical Inc shares in Q1 2021, an estimated $5.05M.
  • UBS O'Connor first reported a position in Strata Critical Medical Inc in Q4 2019 and held it in 5 quarters.
  • UBS O'Connor's Strata Critical Medical Inc position peaked at $26.2M in Q4 2019.
  • 64 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2021.

Based on UBS O'Connor's 13F filing for Q1 2021, filed 14 May 2021.